PEOPLE - Cardio Technologies makes the following organisational changes:
This article was originally published in Clinica
US critical care products manufacturer Cardio Technologies has made the following organisational changes. Thomas Wood becomes president and CEO, and Lawrence Bartz vice-president of finance and chief financial officer. Both are from US Surgical. John Bichan joins as vice-president marketing from Genzyme Surgical Products, and Robert Reinhardt as director of engineering from Cordis.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.